Weight Watchers is buying a telehealth provider that prescribes sought-after weight-management and diabetes drugs in a deal that reinforces how a new class of therapies has revolutionized the way many Americans think about weight loss.
WW International Inc. WW announced Monday night that it’s spending $132 million to buy Weekend Health Inc., a privately held company that operates a telehealth platform called Sequence that is focused on weight management. Despite profoundly lackluster results in the fourth quarter, and stalled subscriber growth, WW’s shares soared on the news that the company is entering the GLP-1 market. The stock was up about 40% in trading on Tuesday.
I’m diabetic, I went to the pharmacy to pick up my prescription for Ozempic, I was told there was a shortage, they didn’t know when it was coming, so while waiting my blood sugar went yo 800, & I was hospitalized for 4 days trying to get my blood sugar under control. Shame on you